Marc Henis

3.3k total citations · 1 hit paper
12 papers, 2.3k citations indexed

About

Marc Henis is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marc Henis has authored 12 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 3 papers in Surgery and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marc Henis's work include Heart Failure Treatment and Management (5 papers), Cardiovascular Function and Risk Factors (5 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). Marc Henis is often cited by papers focused on Heart Failure Treatment and Management (5 papers), Cardiovascular Function and Risk Factors (5 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). Marc Henis collaborates with scholars based in United States, Italy and Sweden. Marc Henis's co-authors include Marc A. Pfeffer, John J.V. McMurray, Jean‐Lucien Rouleau, Eric J. Velazquez, Robert M. Califf, Jeffrey D. Leimberger, Frans Van de Werf, Aldo P. Maggioni, Mary Ann Sellers and Susan Edwards and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Marc Henis

12 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

2003 1.7k citations Marc A. Pfeffer, John J.V. McMurray et al. New England Journal of Medicine profile →

Peers

Marc Henis

CCM

EDM

SURGE

RNMI

PRM

Mary Ann Sellers United States

B. Pitt United States

Franz H. Messerli United States

Peter Aurup United States

James M. McLenachan United Kingdom

Henning Bagger Denmark

YannTong Chiang United States

N Pauly United Kingdom

Felipe A Martinez United States

Michael Klibaner United States

Mary Ann Sellers United States

Marc Henis

1.9k ×0.9

CCM

525 ×0.8

EDM

294 ×1.0

SURGE

188 ×0.9

RNMI

277 ×1.4

PRM

Citations per year, relative to Marc Henis Marc Henis (= 1×) peers Mary Ann Sellers

Countries citing papers authored by Marc Henis

Since Specialization

Citations

This map shows the geographic impact of Marc Henis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Henis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Henis more than expected).

Fields of papers citing papers by Marc Henis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Henis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Henis. The network helps show where Marc Henis may publish in the future.

Co-authorship network of co-authors of Marc Henis

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Henis. A scholar is included among the top collaborators of Marc Henis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Henis. Marc Henis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Aguilar, David, Scott D. Solomon, Lars Køber, et al.. (2004). Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction. Circulation. 110(12). 1572–1578. 170 indexed citations

2.

Aguilar, David, Scott D. Solomon, Lars Køber, et al.. (2003). Impact of known and newly diagnosed diabetes mellitus after a myocardial infarction. Journal of the American College of Cardiology. 41(6). 345–346. 1 indexed citations

3.

Velazquez, Eric J., Marc A. Pfeffer, John J.V. McMurray, et al.. (2003). VALsartan In Acute Myocardial Infarction (VALIANT) Trial: Baseline Characteristics in Context. European Journal of Heart Failure. 5(4). 537–544. 60 indexed citations

4.

Velazquez, Eric J., W. Douglas Weaver, Paul W. Armstrong, et al.. (2003). Heart failure and/or left ventricular systolic dysfunction complicating myocardial infarction is common and accounts for the majority of in-hospital myocardial infarction mortality: Results of the VALIANT registry. Journal of the American College of Cardiology. 41(6). 148–148. 3 indexed citations

5.

Califf, Robert M., Marc A. Pfeffer, John J.V. McMurray, et al.. (2003). Early use of beta-blockade in complicated myocardial infarction: The VALIANT trial. Journal of the American College of Cardiology. 41(6). 322–322. 1 indexed citations

6.

Pfeffer, Marc A., John J.V. McMurray, Eric J. Velazquez, et al.. (2003). Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both. New England Journal of Medicine. 349(20). 1893–1906. 1676 indexed citations breakdown →

7.

Kjeldsen, Sverre E., Stevo Julius, Hans R. Brunner, et al.. (2001). Characteristics of 15314 Hypertensive Patients at High Coronary Risk. The VALUE Trial. Blood Pressure. 10(2). 83–91. 67 indexed citations

8.

Pfeffer, Marc A., John J.V. McMurray, Alain Leizorovicz, et al.. (2000). Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design. American Heart Journal. 140(5). 727–750. 139 indexed citations

9.

Franciosa, Joseph A., Karl T. Weber, T. Barry Levine, et al.. (1982). Hydralazine in the long-term treatment of chronic heart failure: Lack of difference from placebo. American Heart Journal. 104(3). 587–594. 138 indexed citations

10.

Smith, Peter R., et al.. (1977). A Comparative Study of Subcutaneously Administered Terbutaline and Epinephrine in the Treatment of Acute Bronchial Asthma. CHEST Journal. 71(2). 129–134. 22 indexed citations

11.

Chatterjee, Kanu, Swan Hj, William Ganz, et al.. (1975). Improved angina threshold and coronary reserve following direct myocardial revascularization.. PubMed. 52(2 Suppl). I81–92. 11 indexed citations

12.

Chatterjee, Kanu, Jack M. Matloff, H. J. C. Swan, et al.. (1975). Abnormal regional metabolism and mechanical function in patients with ischemic heart diseases: improvement after successful regional revascularization by aortocoronary bypass.. Circulation. 52(3). 390–399. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact